Support: +91-22-61011756 /
1. Boolean Searches :

i. AND - Shows results where both terms on either side of the 'AND' operator are present. 'AND' must be in upper case. For example search term - delhi AND metro result - It will return records in which 'delhi' as well as 'metro' both are present.

ii. OR - Shows results where either term (or both terms) is present. 'OR' must be in upper case. For example search term - delhi OR metro result - It will return records in which either 'delhi' or 'metro' or both are present

2. Proximity Searches

A proximity search looks for terms that are within a specific distance from one another. For example, search term - 'delhi metro'~10 result - It will search for records where 'delhi' and 'metro' are found within 10 words of each other

3. Phrase searches

You can search phrases using double quotes. for e.g. 'delhi metro' result - It will return records where 'delhi metro' phrase is found.

Laurus Labs steps up R&D initiatives with a pipeline of 60 products

Friday, 12 May 2023
Share this on :

Laurus Labs has stepped up its Research and Development (R&D) initiatives with a pipeline of 60 products. Its sterile R&D labs, commissioned in 2022, are already working on several priority projects, which are either under review or under development, having a market size of over USD 40 billion.

Laurus has also invested in ImmnoACT, which set up an advanced GMP CAR-T cell therapy facility in Mumbai, and initiated a Phase-II for HCAR-19 in lymphoma and Leukemia, post positive Phase-I data results.

During FY23, Laurus filed its first New Drug Application (NDA) for novel HIV-pediatric product using oral dissolving film technology, and aspires to set an innovative pipeline in other therapeutic areas.

Further, the investment made towards expanding non-ARV formulation infrastructure with a total commissioned capacity of 10 billion units will be complemented by an improved demand visibility in ARV business, CMO portfolio, as also key product approvals across the US, Europe and Canada.

In its portfolio-led investment, the company has a product-specific approach based on complexity and economies of scale, and will prioritise disruptive technologies that blend scientific opportunity and value.

The Hyderabad-based company, clocked Rs 6,041 crore revenue in FY23 marking a 22 percent increase over the previous year,with a 3.5 percent spend on R&D in the last financial year (FY).

Post Your Comments


Free access to Project News and Analysis

Project and Tender Alert in your mailbox

Explore the largest Database on Projects for free

Be part of Online Projects Community

User login
Start Exploring

Subscribe to any of our premium plans to

Access to complete information on 43000+ projects

Use our Notification service for instant update on projects and tenders

Closely monitor your opportunities with "WORKSPACE"

Use our online platform for promotions of your products and services